Hem › Interstitiella lungsjukdomar › Colorado
Kliniska studier för Interstitiella lungsjukdomar i Colorado
15 studier för Interstitiella lungsjukdomar söker deltagare vid platser i Colorado.
Städer i Colorado
Officiell studietext (engelska)
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- University of Colorado Denver, Aurora
RekryterarFas 3
Ålder 40 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT07201922LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Colorado, Denver
- National Jewish Hospital, Denver
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 29 sep. 2026 · NCT05798923A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Aurora
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT05878717A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- National Jewish Health, Denver
RekryterarFas 2
Ålder 40 och äldre · Alla kön · Uppdaterad 4 sep. 2026 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- National Jewish Health, Denver
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 2 sep. 2026 · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- University of Colorado Hospital, Aurora
- National Jewish Hospital, Denver
RekryterarFas 3
Ålder 18 till 80 · Alla kön · Uppdaterad 2 sep. 2026 · NCT07285655DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Colorado - Anschutz Medical Campus, Aurora
- National Jewish Health, Denver
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 26 aug. 2026 · NCT06388421PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
- University of Colorado | Anschutz Medical Campus, Aurora
RekryterarObservationsstudie
Ålder 18 till 80 · Alla kön · Uppdaterad 18 aug. 2026 · NCT06855329Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Colorado, Aurora
RekryterarObservationsstudie
Ålder 21 och äldre · Alla kön · Uppdaterad 12 aug. 2026 · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- University of Colorado, Aurora
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 10 aug. 2026 · NCT07175038An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- National Jewish Health, Denver
RekryterarObservationsstudie
Ålder 18 till 80 · Alla kön · Uppdaterad 26 juni 2026 · NCT06129240A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
- GSK Investigational Site, Aurora
RekryterarFas 1Friska volontärer välkomna
Ålder 18 till 65 · Alla kön · Uppdaterad 22 juni 2026 · NCT06576271TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- Children's Hospital Colorado, Aurora
RekryterarObservationsstudie
Upp till ålder 24 · Alla kön · Uppdaterad 22 juni 2026 · NCT04098445Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
- University of Colorado - Anschutz Medical Campus, Aurora
RekryterarObservationsstudie
Ålder 45 till 90 · Alla kön · Uppdaterad 1 maj 2026 · NCT03297775Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
- University of Colorado Denver, Aurora
RekryterarObservationsstudie
Ålder 18 till 90 · Alla kön · Uppdaterad 3 maj 2024 · NCT06397677Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.